Eli Lilly (NYSE: LLY) stock has soared 90% over the past year, a huge gain for a pharmaceutical company. These stocks generally are known for steady increases over time instead of big movements over a year or two. And this follows the pace of their earnings, which also are progressive over time -- even in difficult economies -- as people always need their medicines.

So why is Eli Lilly standing out from the crowd? Over the years, this pharma giant has delivered the steady earnings growth that its industry is known for -- but it's also seen an enormous boost to revenue more recently thanks to its specialty in one particular area. I'm talking about weight loss drugs. Lilly sells Mounjaro and Zepbound, two that doctors regularly prescribe to their patients.

As a result, Lilly's earnings and stock performance have surged. But does this make Lilly the best pharma stock for you? Let's find out.

Continue reading

Source Fool.com